Quick Order Cart

Cat. No. ARG40243

Dnm1l Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

This product consists of a CRISPR/Cas9-edited polyclonal knockout cell population targeting the DNM1L gene (encoding DRP1) in HEK293T cells. DRP1 is a dynamin-related GTPase that drives mitochondrial and peroxisomal fission, regulated by adaptors such as MFF, MIEF1/2, and Fis1, and phosphorylated by CDK1, AMPK, and other kinases. Its loss disrupts organelle dynamics, mitophagy, and cytochrome c/caspase-mediated apoptosis. These polyclonal knockout cells serve as a versatile model for investigating mitochondrial network remodeling, apoptotic signaling, and metabolic flux, with applications in neurodegeneration research, cancer cell metabolism studies, and drug discovery for mitochondrial diseases.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    DNM1L

    Gene Identifier

    NCBI Gene ID 10059

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNM1L Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population in which the DNM1L gene, encoding the dynamin-related GTPase DRP1, has been disrupted. This loss-of-function model provides a genetically defined system for dissecting mitochondrial and peroxisomal fission mechanisms without clonal artifacts. The polyclonal format preserves heterogeneous editing events, offering a reproducible platform for functional studies of organelle dynamics, apoptosis, and metabolic regulation in a widely used human cell background.

HEK293T cells are human embryonic kidney epithelial cells that stably express the SV40 large T antigen, enabling episomal replication of SV40 origin-containing plasmids. This feature, combined with high transfectability and robust protein expression capacity, makes HEK293T a preferred host for exogenous gene expression, lentiviral and retroviral packaging, and CRISPR-based genome engineering. The cells’ epithelial origin and ease of manipulation facilitate detailed cell biological analyses, including live-cell imaging and biochemical fractionation, making them an ideal chassis for investigating mitochondrial network dynamics upon DNM1L disruption.

DNM1L/DRP1 is a cytosolic GTPase that translocates to the mitochondrial outer membrane in response to cellular cues, where it is recruited by adaptors MFF, MIEF1 (MiD49), and MIEF2 (MiD51), and cooperates with Fis1 to oligomerize into helical filaments that constrict and sever the organelle. Its activity is tightly regulated by phosphorylation through cyclin-dependent kinases (CDK1, CDK5), AMPK, PKA, CaMKII, and ERK1/2. Downstream of DRP1-mediated fission, mitochondrial fragmentation facilitates cytochrome c release and activation of caspase-9 and caspase-3, linking organelle shape to apoptosis. DRP1 also interacts with GDAP1, Bax, Bak, and OPA1-containing complexes, underscoring its central role in mitochondrial quality control and cell death pathways.

In the HEK293T background, knockout of DNM1L leads to a striking hyperfused mitochondrial reticulum, impaired mitophagy flux, and resistance to intrinsic apoptosis, mirroring phenotypes observed in primary cells and disease models. This polyclonal knockout population enables robust investigation of fission-dependent processes, including mtDNA distribution, mitochondrial calcium handling, and metabolic reprogramming, without confounding clonal selection effects. The model is particularly valuable for studying how upstream regulatory kinases and adaptor proteins modulate DRP1 localization and activity in a tractable epithelial system.

Representative applications include immunofluorescence-based mitochondrial morphology scoring, Seahorse metabolic flux analysis to assess oxidative phosphorylation and glycolysis, caspase-3/7 activation assays for apoptosis profiling, and mitophagy flux measurements using pH-sensitive reporters. The knockout cells are also suitable for drug screening targeting mitochondrial disorders and for co-expression studies with fluorescent organelle markers. For additional technical specifications, protocols, or custom services, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)